Biochemical and growth‐modulatory effects of the new S‐adenosylmethionine decarboxylase inhibitor CGP 48664 in malignant and immortalized normal human breast epithelial cells in culture
- 9 August 1995
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 62 (4) , 485-491
- https://doi.org/10.1002/ijc.2910620421
Abstract
CGP 48664 [4-aminoindanon-1-(2′-amidino)hydrazone dihydrochloride monohydrate] is a newly introduced inhibitor of S-adenosyltnethionine decarboxylase (SAMDC) with increased selectivity of action and reduced toxichy. We analyzed the biochemical and antiproliferative effects of this compound in a panel of hormone-dependent (3 clones of MCF-7, T47D) and -independent (MDA-MB-231, BT-20) human breast cancer cell lines in culture. For comparison, we also tested its effects in the spontaneously immortalized human breast epithelial cell line MCF-10A. All cell lines were highly sensitive to the growth-inhibitory effect of CGP 48664 with an IC50 between 0.1 and 0.5 μM. A dose-dependent bell-shaped increase in SAMDC was observed in normal and malignant breast cells resulting from enzyme stabilization by the inhibitor as supported by Western blot analysis. While omithine decarboxylase (ODC) activity consistently increased, the effect of CGP 48664 on spermidine J. spermine N′acetyltransferase (SSAT) was variable in the breast cancer cell lines. In contrast, the inhibitor consistently reduced SSAT activity level in the MCF-10A cell line and its derivative partially transformed by a mutated ras oncogene. As expected, cellular putrescine levels were markedly increased by CGP 48664 administration, whereas spermidine and spermine contents were reduced. However, the degree of reduction was usually only moderate. Furthermore, exogenous polyamine administration was relatively ineffective in rescuing the antiproliferative effect of CGP 48664 in MCF-7 cells, while exerting a more complete rescue in the MDA-MB-231 cell line. We conclude that CGP 48664 exerts a potent growth-inhibitory effect on mammary cells in culture. However, its action may not always be entirely mediated through the polyamine pathway.Keywords
This publication has 19 references indexed in Scilit:
- Phenotypic features of breast cancer cells overexpressing ornithine‐decarboxylaseJournal of Cellular Physiology, 1995
- Stable Amplification of the S-Adenosylmethionine Decarboxylase Gene in Chinese Hamster Ovary CellsJournal of Biological Chemistry, 1995
- Estradiol control of ornithine decarboxylase mRNA, enzyme activity, and polyamine levels in MCF-7 breast cancer cells: therapeutic implicationsBreast Cancer Research and Treatment, 1994
- Polyamine involvement in basal and estradiol-stimulated insulin-like growth factor I secretion and action in breast cancer cells in cultureThe Journal of Steroid Biochemistry and Molecular Biology, 1990
- An evaluation of the involvement of polyamines in modulating MCF-7 human breast cancer cell proliferation and progesterone receptor levels by estrogen and antiestrogenThe Journal of Steroid Biochemistry and Molecular Biology, 1987
- Polyamines and growth regulation of cultured human breast cancer cells by 17β-oestradiolMolecular and Cellular Endocrinology, 1986
- Aspects of the biochemical pharmacology of methyl glyoxal bis(guanylhydrazone)Biochemical Pharmacology, 1986
- Differential inhibition of histone and polyamine acetylases by multisubstrate analogsBiochemistry, 1984
- [39] S-adenosylmethionine decarboxylase (rat liver)Published by Elsevier ,1983
- Methyl glyoxal bis(guanylhydrazone) as a potent inhibitor of mammalian and yeast S-adenosylmethionine decarboxylasesBiochemical and Biophysical Research Communications, 1972